Investing.com -- Bernstein reiterated its Outperform rating on Novo Nordisk, saying the company’s diabetes and obesity GLP-1 portfolio remains well-positioned following fresh data from the European ...

Like many GLP-1 medications approved for diabetes, however, weight loss is a side effect of Rybelsus. “Data has shown modest ...

On Super 6, the lead story is the legal battle initiated by former NCB officer Sameer Wankhede, who has filed a two crore rupees defamation lawsuit against Shah Rukh Khan's Red Chillies Entertainment, ...

Biomedical scientist Dr. Avi Roy discussed the future of human longevity, stating it may be possible to 'stay in your 30s for hundreds of years.' In an interview with India Today, Dr. Roy explained ...

During a session on the rise of GLP-1 medications, leading medical experts unpacked the complexities of obesity in India. Dr. Muffazal Lakdawala called these medications as surgery in a pill.

The 43-year-old retired tennis champ showcased her substantial weight loss in a animal-print teddy over black leggings, ...

After a couple failed attempts on its own, Pfizer is hitting the M&A gas to bring in candidates that could help it become a ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

New York City doctors reveals how weight-loss drugs reduce inflammatory cytokines by decreasing fat cells, potentially preventing cancer and autoimmune diseases.

Longevity doctors warn GLP-1 drugs may cost patients muscle, not just fat. ShapeScale’s 3D scans reveal the loss—and help ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Starbucks is laying off around 900 non-retail employees and closing some U.S. and Canadian stores as it focuses more of its ...